Clinical trial
A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia
NCT00002154 · The Dana Foundation, Other · Completed
Key facts
| NCT number | NCT00002154 |
|---|---|
| Title | A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia |
| Official title | Parallel Group, Placebo-Controlled, Tolerability and Safety Study of Thioctic Acid and Deprenyl in HIV Dementia |
| Lead sponsor | The Dana Foundation, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cognitive Disorders, HIV Infections |
| Intervention type | Drug |
| Interventions | Thioctic acid, Selegiline hydrochloride |
| Enrollment | 32 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: